Skip to content
info@acplgroupindia.co.in +91-9266665201 Mon – Sat: 10:00 AM – 6:00 PM
Accredited Consultant
  • Home
  • About
  • Services

    • Regulatory Services

      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology

    • Specialized Services

      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials

    • More Services

      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • Blog
  • Contact
Get Started
Accredited Consultant
  • Home
  • About
  • Services
    • Regulatory Services
      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology
    • Specialized Services
      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials
    • More Services
      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • Blog
  • Contact
Call Us: +91-9266665201 info@acplgroupindia.co.in
  1. Home
  2. Central drugs registration in india

Central drugs registration in india

December 4, 2025 drug & medical registration
← Previous drug & medical registration in India Next → New drug & medical registration in India

Recent Posts

  • Plastic EPR Enforcement 2026: Audits, Customs Blocks & Penalties Jul 27, 2026
  • Navigating the Latest CDSCO Circular: What It Means for India’s Cosmetics Sector Jul 25, 2026
  • DSCO Prohibits 16 Fixed Dose Combinations (FDCs): Key Regulatory Update for the Pharmaceutical Industry Jul 23, 2026
  • CDSCO Issues Final Guidance on Medical Device Software under MDR 2017: What Manufacturers Need to Know Jul 23, 2026
  • Footwear QCO 2026: DPIIT Extends Stock Deadline to 2027 Jul 20, 2026

Need Regulatory Guidance?

Our team of 18+ experts is ready to help with your regulatory challenges.

Contact Us
Accredited Consultant

India's trusted pharma regulatory affairs consultancy. Over 25 years helping businesses navigate CDSCO, FSSAI, BIS, and all major Indian regulatory frameworks.

Quick Links

  • About ACPL
  • Our Services
  • India Entry Strategy
  • Insights & Blog
  • Contact Us
  • Careers

Key Services

  • CDSCO Registration
  • FSSAI Licensing
  • BIS Certification
  • Pharmacovigilance
  • Clinical Trials
  • EPR Registration

Contact Us

  • B-3, Sector-6, Noida – 201301, Uttar Pradesh, India
  • +91-9266665201
    +91-9310040434
  • info@acplgroupindia.co.in
  • Mon – Sat: 10:00 AM – 6:00 PM

© 2026 Accredited Consultants Private Limited. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
Scroll to Top